MLchartDataset catalogue

autologous mDC3 vaccine

Term · Oncology and biomedicine · MLC-T-ONC-011688

An antineoplastic vaccine composed of autologous mature dendritic cells (mDCs) pulsed with mutated peptides, with potential immunostimulating and antineoplastic activities. Upon administration, the autologous mDC3 vaccine may elicit a cytotoxic T-cell (CTL) response against cancer cells.

Table 1. Record
IdentifierMLC-T-ONC-011688
FieldOncology and biomedicine
Synonymsautologous mature DC3 vaccine; autologous peptide-pulsed mDC3 vaccine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011688",
  "term": "autologous mDC3 vaccine",
  "field": "Oncology and biomedicine",
  "definition": "An antineoplastic vaccine composed of autologous mature dendritic cells (mDCs) pulsed with mutated peptides, with potential immunostimulating and antineoplastic activities. Upon administration, the autologous mDC3 vaccine may elicit a cytotoxic T-cell (CTL) response against cancer cells.",
  "synonyms": [
    "autologous mature DC3 vaccine",
    "autologous peptide-pulsed mDC3 vaccine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-mdc3-vaccine/"
}

Record 3,024 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.